The civil society monitoring of hepatitis C response related to the WHO 2030 elimination goals in 35 European countries

BACKGROUND: People who inject drugs (PWID) account for the majority of new cases of hepatitis C virus (HCV) infection in Europe; however, HCV testing, and treatment for PWID remain suboptimal. With the advent of direct acting antivirals (DAAs) the World Health Organization (WHO) adopted a strategy t...

Descripción completa

Detalles Bibliográficos
Autores principales: Maticic, M., Pirnat, Z., Leicht, A., Zimmermann, R., Windelinck, T., Jauffret-Roustide, M., Duffell, E., Tammi, T., Schatz, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678126/
https://www.ncbi.nlm.nih.gov/pubmed/33213481
http://dx.doi.org/10.1186/s12954-020-00439-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678126/
https://www.ncbi.nlm.nih.gov/pubmed/33213481
http://dx.doi.org/10.1186/s12954-020-00439-3

Ejemplares similares